About this trial
Epilepsy affects millions worldwide, with 40% of patients experiencing uncontrolled seizures despite medication. Comprehensive epilepsy centers recommend continuous video-electroencephalography monitoring to define seizure type and distinguish mimickers. This process, however, is resource-intensive, with lengthy hospital stays. The investigators' recent study identified a heightened association between arousals and epileptic activity in drug-resistant focal epilepsy patients. Building on these findings, the investigators aim to explore whether disrupting sleep with an alarm system triggers earlier occurrence of seizures, potentially offering insights to reduce hospital stay durations in epilepsy monitoring units.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 14 to 60 years
EMU monitoring for presurgical evaluations
Average 2-3 seizures per week based on pre-admission seizure diary
Sleep as a known seizure trigger
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Alarm system
DeviceGeneric alarm system programmed to sound during the night to try to induce arousals from sleep.
Treatment groups
Trial outcomes
Primary outcomes
Seizure frequency during EMU (epilepsy monitoring unit) stay
Average number of seizures per day, recorded daily during the patient's EMU stay. Measured for all groups of patients.
Duration of EMU (epilepsy monitoring unit) admission
Overall duration (in days) of the EMU admission. Measured for all groups of patients.
Average interictal spike rates
Average number of spike rates, taken from a random segment for each day and night. Measured for all groups of patients.
Change in sleep quality
As determined by changes in Pittsburgh Sleep Quality Index scores. A higher score indicates increased sleep disturbances.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: